Table 3. koff values (s-1) of statistically significant comparisons of interactions between groups of patient sera and peptides.
Peptide |
Peptide P30
|
Peptide P6
|
Peptide P7
|
Peptide P14
|
Peptide P20
|
Peptide P39
|
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
p-value | p=0.004 |
p=0.01 |
p=0.01 |
p=0.006 |
p=0.004 |
p=0.01 |
||||||
Group | AIH | SLE | AIH | RA | AIH | RA | SLE | RA | SLE | RA | SLE | RA |
n | 7 | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 7 | 7 | 7 | 6 |
koff serum 1 | 0.00105 | 0.00188 | 0.00150 | 0.00296 | 0.00150 | 0.00296 | 0.00327 | 0.00166 | 0.00234 | 0.00160 | 0.00289 | 0.00118 |
koff serum 2 | ND | 0.00524 | 0.00158 | 0.00172 | 0.00158 | 0.00172 | 0.00681 | 0.00248 | 0.00350 | ND | 0.00670 | ND |
koff serum 3 | 0.00290 | 0.00461 | 0.00112 | 0.00239 | 0.00112 | 0.00239 | 0.00296 | 0.00165 | 0.00433 | 0.00192 | 0.00764 | 0.00160 |
koff serum 4 | 0.00143 | 0.00370 | 0.00229 | 0.00281 | 0.00229 | 0.00281 | 0.00233 | 0.00254 | 0.00387 | 0.00215 | 0.00224 | 0.00102 |
koff serum 5 | 0.00256 | 0.00495 | 0.00177 | 0.00171 | 0.00177 | 0.00171 | ND | 0.00254 | 0.00242 | 0.00228 | 0.00249 | ND |
koff serum 6 | 0.00180 | 0.00686 | 0.00123 | 0.00250 | 0.00123 | 0.00250 | 0.00353 | 0.00176 | 0.00478 | 0.00194 | ND | 0.00188 |
koff serum 7 | 0.00134 | 0.00435 | 0.00190 | 0.00251 | 0.00190 | 0.00251 | 0.00343 | 0.00266 | 0.00618 | 0.00246 | 0.00160 | 0.00230 |
koff serum 8 | 0.00350 | 0.00689 | 0.00176 | 0.00253 | 0.00176 | 0.00253 | 0.00839 | 0.00170 | ND | 0.00155 | 0.00387 | 0.00047 |
koff values in s-1 ; Kruskal Wallis test, Dunn-Sidak’s correction, p-value ≤ 0.017. ND, not determined; ND, not determined; AIH autoimmune hepatitis; SLE systemic lupus erythematosus; RA Rheumatoid arthritis.